Peer Review reports
From: SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets
| Original Submission | ||
|---|---|---|
| 8 Dec 2020 | Submitted | Original manuscript |
| 28 Dec 2020 | Reviewed | Reviewer Report |
| 8 Jan 2021 | Reviewed | Reviewer Report |
| 3 Feb 2021 | Author responded | Author comments - Moom Roosan |
| Resubmission - Version 2 | ||
| 3 Feb 2021 | Submitted | Manuscript version 2 |
| 4 Feb 2021 | Reviewed | Reviewer Report |
| 5 Feb 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Publishing | ||
| 5 Feb 2021 | Editorially accepted | |
| 18 Feb 2021 | Article published | 10.1186/s12864-021-07433-4 |
You can find further information about peer review here.